Literature DB >> 10424729

Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey.

S Paydas1, B Kiliç, B Sahin, R Buğdayci.   

Abstract

Anti-hepatitis C virus (HCV) antibody prevalence was investigated in 228 patients with lymphoproliferative disorders (LPDs). Twenty-six of 228 (11.40%) patients with LPDs were positive for anti-HCV which was higher than the donor population (P = 0.0007). Nine of 98 cases with non-Hodgkin's lymphoma, five of 47 cases with multiple myeloma, seven of 36 cases with Hodgkin's disease, four of 38 cases with chronic lymphocytic leukaemia and one of nine cases with acute lymphoblastic leukaemia had anti-HCV antibody. In all patients, odds ratio (OR) for anti-HCV was 24.09. This value was higher in patients less than 35 years as 62.04 for below 25 years and 32.00 for between 25-35 years. Our findings suggest that HCV infection might be a causative and/or contributing factor in lymphoproliferation.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10424729      PMCID： PMC2363073          DOI： 10.1038/sj.bjc.6690522

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  22 in total

1.  Waldenström macroglobulinemia: a role of HCV infection?

Authors:  G F Santini; M Crovatto; M L Modolo; P Martelli; C Silvia; G Mazzi; F Franzin; M Moretti; P Tulissi; G Pozzato
Journal:  Blood       Date:  1993-11-01       Impact factor: 22.113

2.  Hepatitis C virus infection in patients with lymphoproliferative disorders.

Authors:  D McColl M; R C Tait
Journal:  Br J Haematol       Date:  1996-03       Impact factor: 6.998

3.  HCV and non-Hodgkin lymphoma.

Authors:  P Pioltelli; G Zehender; G Monti; A Monteverde; M Galli
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

4.  Monoclonal gammopathies and hepatitis C virus infection.

Authors:  C Mussini; M Ghini; M T Mascia; P Giovanardi; G Zanni; I Lattuada; S Moreali; G Longo; M G Ferrari; G Torelli
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

5.  Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia.

Authors:  G Pozzato; C Mazzaro; M Crovatto; M L Modolo; S Ceselli; G Mazzi; S Sulfaro; F Franzin; P Tulissi; M Moretti
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

6.  Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.

Authors:  C Ferri; F Caracciolo; A L Zignego; L La Civita; M Monti; G Longombardo; F Lombardini; F Greco; E Capochiani; A Mazzoni
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

7.  A role for hepatitis C virus infection in type II cryoglobulinemia.

Authors:  V Agnello; R T Chung; L M Kaplan
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

8.  Mixed cryoglobulinemia and hepatitis C virus.

Authors:  P Cacoub; F L Fabiani; L Musset; M Perrin; L Frangeul; J M Leger; J M Huraux; J C Piette; P Godeau
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

9.  Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.

Authors:  C Ferri; M Monti; L La Civita; G Longombardo; F Greco; G Pasero; P Gentilini; S Bombardieri; A L Zignego
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

10.  Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma.

Authors:  S De Vita; V Zagonel; A Russo; M Rupolo; R Cannizzaro; G Chiara; M Boiocchi; A Carbone; S Franceschi
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
View more
  8 in total

Review 1.  Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

Authors:  Clodoveo Ferri; Marco Sebastiani; Dilia Giuggioli; Michele Colaci; Poupak Fallahi; Alessia Piluso; Alessandro Antonelli; Anna Linda Zignego
Journal:  World J Hepatol       Date:  2015-03-27

2.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia.

Authors:  S Gharagozloo; J Khoshnoodi; F Shokri
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 3.  Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

Authors:  Carlo Visco; Silvia Finotto
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders.

Authors:  Vahap Okan; Mehmet Yilmaz; Aysen Bayram; Cem Kis; Sami Cifci; Hakan Buyukhatipoglu; Mustafa Pehlivan
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

Review 5.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

6.  Outcome of combination antiviral therapy in chronic hepatitis C virus infection during therapy of acute lymphoblastic leukemia.

Authors:  Muhammad Ayyub; Soha A El-Moursy; Fahd Al-Abbas
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

Review 7.  Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea.

Authors:  Hogil Kim; Yun Kyung Chung; Inah Kim
Journal:  Ann Occup Environ Med       Date:  2018-01-31

8.  Treatment of Hepatitis C in a Case of Pediatric B-Cell Acute Leukemia.

Authors:  Nikita Jakhar; Akriti Gera; Richa Mittal; Sumit Mehndiratta; Amitabh Singh
Journal:  J Glob Infect Dis       Date:  2021-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.